Cortisol Response to Moderate & Deep Sedation in Children

Status Completed

Clinical Trial Summary

Currently, it is unknown whether sedation itself induces a rise in serum cortisol levels or if cortisol levels rise under only the most invasive of procedures, regardless of the type of anesthetic agent used. Animal data shows significant alterations in steroid intermediates under anesthesia regardless of the procedure performed. Prior studies in children show general anesthesia and even epidural anesthesia can cause a rise in serum cortisol, but the effects of moderate and deep sedation on cortisol levels during different types of procedures are unknown. General medical practice varies considerably among providers; some provide stress dosing (extra and sometimes high doses of steroids) for sedation for both non-invasive and invasive procedures for patients with known adrenal insufficiency, but the doses given vary considerably. Others provide stress dosing only for the most invasive procedures in this population of patients. Currently there is no published normative data on changes in cortisol levels under moderate and deep sedation in adrenally sufficient children, so the normal response we are trying to mimic is unknown.

We propose to measure salivary cortisol levels prospectively in adrenally sufficient children undergoing moderate and deep sedation to determine the normal cortisol response to the stress of sedation for both invasive and non-invasive procedures.

Up to 300 adrenally sufficient children will be prospectively recruited to measure salivary cortisol levels during moderate and deep sedation for non-invasive procedures (e.g. MRI, echocardiogram, or other imaging studies), and invasive procedures (e.g. surgery, endoscopy) to determine what the normal cortisol response is to the stress of sedation during these procedures using various anesthetic agents.

The primary outcome variable will be to determine peak salivary cortisol measurements during non-invasive and invasive procedures under different levels of sedation using various anesthetic agents, and correlate these with known norms in children to determine if the patient's hypothalamic-pituitary-adrenal axis is under stress.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Adrenal Insufficiency

Clinical Trial Details

NCT number	NCT01265966
Study type	Observational
Source	Tripler Army Medical Center
Contact
Status	Completed
Phase	N/A
Start date	December 2010
Completion date	July 2011

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03282487` - Optimising Steroid Replacement in Patients With Adrenal Insufficiency	Phase 4
Not yet recruiting	`NCT05716607` - Treatment Study in Patients Treated With Both Insulin & Hydrocortisone	N/A
Not yet recruiting	`NCT06435481` - Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics	Phase 4
Recruiting	`NCT03399383` - Adherence in Chronic Adrenal Insufficiency	N/A
Completed	`NCT01428336` - Value of 25 mcg Cortrosyn Stimulation Test	N/A
Completed	`NCT00851942` - Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test	Phase 4
Withdrawn	`NCT00368381` - Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis	Phase 4
Active, not recruiting	`NCT04519580` - Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
Recruiting	`NCT06008184` - Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
Completed	`NCT03013166` - THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone
Enrolling by invitation	`NCT02282150` - Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism	Phase 4
Completed	`NCT02934399` - Dynamic Hormone Diagnostics in Endocrine Disease
Completed	`NCT03000231` - Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
Completed	`NCT01960530` - An Investigational Study of Hydrocortisone	Phase 1
Completed	`NCT00552487` - Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis	N/A
Completed	`NCT00575341` - Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency	Phase 3
Completed	`NCT00471900` - Six Months DHEA Treatment in Female Adrenal Failure	N/A
Completed	`NCT03294876` - Rheumatoid Arthritis Adrenal Recovery Study
Completed	`NCT03709381` - Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study	Early Phase 1
Recruiting	`NCT05639127` - The Treatment of Adrenal Crisis With Inhaled Prednisolone	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cortisol Response to Moderate and Deep Sedation in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms